 Ardelyx Inc NASDAQ: ARDX shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to 5 from 1. Analyst Chris Howerton thinks Ardelyx stands out given that the Company has an approved IBS-C product, Isbrela, that. 